Praxis Precision Medicines, Inc. - 8-K Filing

Praxis Precision Medicines presents commercial strategy for ulixacaltamide and relutrigine alongside expanded pipeline updates at Investor Day. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 12, 2026, 22:01 UTC

Tickers: $PRAX

Read the full article at SEC EDGAR

More Regulatory news

Agassi Sports Entertainment Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:07 UTC
TAP REAL ESTATE TECHNOLOGIES, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:06 UTC
ERock, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:05 UTC
AKAMAI TECHNOLOGIES INC - 8-K Filing SEC EDGAR · November 12, 2026, 22:05 UTC
SMITH MICRO SOFTWARE, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 22:04 UTC
Quoin Pharmaceuticals Ltd. - 8-K Filing SEC EDGAR · November 12, 2026, 22:04 UTC
Proficient Auto Logistics, Inc - 8-K Filing SEC EDGAR · November 12, 2026, 22:03 UTC
Block, Inc. - 4 Filing SEC EDGAR · November 12, 2026, 22:02 UTC
CareView Communications Inc - 10-Q Filing SEC EDGAR · November 12, 2026, 22:02 UTC
NOCOPI TECHNOLOGIES INC/MD/ - 10-Q Filing SEC EDGAR · November 12, 2026, 22:01 UTC